Psoriasis is an immune-mediated chronic inflammatory skin disease. Although its pathogenesis is not fully understood, Th17 cells and the cytokines they produce, such as IL-17, IL-22 and IL-23, play critical roles in the pathogenesis of psoriasis. Evidence has demonstrated that psoriasis has some common features, including immune responses (due to Th17 cells) and inflammatory cytokine profiles, with systematic diseases including inflammatory bowel diseases (IBDs) and obesity. Recently, studies have demonstrated that the gut microbiota plays a crucial role in host homoeostasis and immune response, particular in Th17 cells, but the role of the gut microbiota in psoriasis remains unclear. To study the relationship between gut microbiota and psoriasis, we analysed microbiota profiles in psoriasis using a 16S rDNA sequencing platform, and we found that the abundance of Akkermansia muciniphila was significantly reduced in patients with psoriasis. A. muciniphila is believed to have an important function in the pathogenesis of IBD and obesity; therefore, A. muciniphila, which is an indicator of health status, may be a key node for psoriasis as well as IBD and obesity.
| INTRODUCTION
Psoriasis, an immune-mediated chronic inflammatory skin disease, is characterised by erythema and scales induced by epidermal hyperplasia with regenerative maturation, angiogenesis in the dermis and inflammatory lymphocyte infiltration. [1, 2] Psoriasis affects approximately 2%-3% of the population in Western countries, [3] [4] [5] whereas it affects approximately 0.47% in China; thus, there at least six million estimated patients with psoriasis in China. Although the exact pathogenesis is not fully understood, psoriasis has been considered a complicated disease due to its environmental-immunity interaction based on genetics.
Not only studies in mouse models but also clinical studies in humans have demonstrated that the interleukin (IL)-23/IL-17/IL-22 axes are pivotal signalling pathways in psoriasis [6] [7] [8] [9] ; interestingly, psoriatic susceptibility genes such as IL23A, IL23R and TYK2 can control Th17 immune responses. [10] [11] [12] [13] Th17 cells have been characterised as producing their lineage-associated cytokines, including IL-17, IL-22 and IL-23, [14] which is a subtype of a lineage of CD4+ Th cells for host defense. Among the Th17 cells that produce cytokines, IL-23 and its downstream signalling key molecule STAT3 are well known to be an area of genetic susceptibility for psoriasis pathogenesis. [15, 16] In addition, the STAT3 activated by IL-6 and IL-21 collaborates with transcription factor RORγ to differentiate Th17 from naive T cells. [17] [18] [19] There are more than 100 trillion microorganisms in the human intestine system, composed of more than 1000 species such as bacteria, yeasts and parasites. [20, 21] The gut microbiota plays essential roles in homoeostasis and host health. [20, 22, 23] For example, Bifidobacterium has been documented as a critical gut microbiota anaerobe for host health. [24] [25] [26] The production of Bifidobacteria involves the release of fermented oligosaccharides from complex polysaccharides by bacteroides to generate short-chain fatty acids through acetate and lactate.
In addition, the Bifidobacteria ferment oligosaccharides that have been converted into butyrate, which provides a key source of energy for the colonic mucosa. [27, 28] In general, it is well known that the intestinal microbiota may contribute to the pathogenesis of a variety of diseases, such as Crohn's disease (a type of inflammatory bowel diseases, IBDs) and obesity. [29] [30] [31] [32] The microbiota has been documented as orchestrating the development of a variety of lymphocyte subsets in the gut, including Th17 cells. Compared with other subsets of CD4+ Th cells, Th17 cells are inclined to accumulate in the intestine, which suggests that the development of Th17 cells may be affected by the gut microbiota. [33] [34] [35] [36] In agreement with this concept, evidence has shown that the number of Th17 cells in the intestine is significantly reduced by antibiotic treatment or under germ-free conditions in mice, [37, 38] which supports that the gut microbiota plays a critical role in Th17 cell development.
Accumulating evidence has indicated that psoriasis is clinically relevant to other systematic diseases, including Crohn's disease and obesity. [39] [40] [41] [42] [43] The question that puzzles investigators regards the relationship and common features between psoriasis and those diseases.
Given that the gut microbiota plays a critical role in maintaining systemic homoeostasis, we proposed that the intestinal microbiota might exert a crucial role in psoriasis development, and 16SrDNA-based high-throughput sequencing was performed to explore microbiota statuses in patients with psoriasis.
| MATERIALS AND METHODS

| Sample collection
Healthy controls (n = 14) and patients with vulgaris psoriasis (n = 14)
were recruited at the Xiangya Hospital of Central South University in accordance with the Declaration of Helsinki. This study was ap- (Table S1 ). This study was approved by the Regional Committee of Ethics. Faecal samples were collected and immediately stored at −80°C, and the whole collection procedure was completed within 60 minutes.
| DNA extraction and 16S sequencing
The DNA from stool samples was isolated using an E.Z.N.A. ® Stool DNA Kit (OMEGA, USA), according to the manufacturer's instructions.
The amplification of the V4-conserved region of bacterial 16S rRNA was performed by primers 515F (GTGCCAGCMGCCGCGGTAA) and 806R (GGACTACHVGGGTWTCTAAT). The reactions were followed by exposure to 98°C for 3 minute, 30 cycles of 98°C for 45 seconds, 55°C for 45 seconds, and 72°C for 45 seconds, and a final extension at 72°C for 7 minute. All samples were sequenced on the Illumina
Miseq platform.
| Data analysis
The raw data were filtered to eliminate adapter pollution and low quality to obtain clean reads. Then, paired-end reads with overlap were merged into tags, and tags were clustered into operational taxonomic units (OTUs) at 97% sequence similarity. Taxonomic ranks were assigned to OTU representative sequences using Ribosomal
Database Project (RDP) Naïve Bayesian Classifier v.2.2. Based on the OTU abundance, the OTU of each group was listed, a Venn diagram was drawn by VennDiagram in R (v3.1.1), and then the common and specific OTU IDs were summarised. Based on the OUT abundance information, the relative abundance of each OTU in each sample was calculated, and the PCA of OTUs was performed using the relative abundance value. The software used in this step was the package "ade4" of R (v3.1.1). Finally, alpha diversity, beta diversity and the different species screening were analysed based on OTU and taxonomic ranks. If the two paired-end reads overlapped, the con- The high-quality paired-end reads were combined into tags based on overlaps; 866 889 tags were obtained in total, with 30 960 tags per sample on average, and the average length was 252 bp; (iii) Analysis of community patterns: the tags were clustered into OTUs (operational taxonomic units) using scripts from the USEARCH software (v7.0.1090).
| Statistical analysis
For significant difference analysis between groups of samples (groups ≥2, samples per group ≥3), we used statistical methods to obtain the abundance differences of microbial communities between samples, and FDR (false discovery rate) was adopted to assess the significance of differences. From the results, we can identify the samples that cause the species composition differences between two groups. The significant differences between the groups are analysed at the level of Phylum, Class, Order, Family, Genus and Species. Metastats (http://metastats.cbcb.umd.edu/) and R (v3.1.1) were used to determine which taxonomic groups were significantly different between groups of samples. We adjusted the obtained P-value with a Benjamini-Hochberg false discovery rate correction (function "p.adjust" in the stats package of R (v3.1.1)).
| RESULTS
| Analysis of the similarity and diversity of gut microbial communities between healthy control and psoriasis
We obtained an average of over 30 000 reads per subject based on the 16S rDNA gene amplicon. To study the details of the microbiome, OTU analysis was conducted for OTUs with a 97% similarity cut-off. A Venn diagram visually displayed the number of common/ unique OTUs in multisamples/groups, and the result showed that approximately 70% of the OTUs were shared between the two groups, while 118 and 135 OTUs were individual to the healthy control and psoriasis groups, respectively, as shown in Figure 1A . Next, principal component analysis (PCA) was performed to assess the differences of microbial communities between these two groups, and we found that the healthy control and psoriasis groups were slightly separated ( Figure 1B ). The Unweighted Pair Group Method with Arithmetic Mean (UPGMA) is a type of hierarchical clustering method based on average linkage, which was used to interpret the distance matrix produced by beta diversity, and the result indicated that most subjects were clustered within either the healthy control or the psoriasis group ( Figure 1C) , suggesting there are significant differences between these two groups. The Chao and Shannon index was used to estimate the alpha diversity. Although there are no significant differences between the two groups ( Figure 1D ), the subjects with psoriasis showed slightly decreased diversity compared with healthy controls ( Figure 1D ).
| The gut microbiota alterations in psoriasis
We analysed the microbial composition in the healthy control and psoriasis groups. At the phylum level, we found that the relative abundance of Verrucomicrobia and Tenericutes was dramatically decreased in patients with psoriasis (Figures 2A and S1A) . In addition, at the class and order level, the abundance of Mollicutes and Verrucomicrobiae, as well as Verrucomicrobiaes and RF39, was also reduced in patients with psoriasis (Figures 2B,C and S1B,C).
At the family level, the relative abundance of Verrucomicrobiaceae and S24-7 was decreased, whereas the relative abundance of
Bacteroidaceae and Enterococcaceae was increased in psoriasis F I G U R E 1 Gut microbial diversity in patients with psoriasis and healthy controls. A, Venn diagram showed the difference in operational taxonomic units (OTUs) in psoriasis and healthy control groups. B, Principal component analysis (PCA) analysed the similarity of microbiota (OTUs) between the psoriasis and healthy control groups. Data from the psoriasis and healthy control groups were plotted on the first two principal components of the OTU profiles. C, The Unweighted Pair Group Method with Arithmetic Mean (UPGMA) was performed to interpret the distance matrix between the psoriasis and healthy control groups. D, Alpha diversity analysis of the two groups. The different methods were computed for all subjects. The box depicts the interquartile range (IQR) between the first and third quartiles (25th and 75th percentiles, respectively), and the line inside the box denotes the median
The relative abundance of the microbiota analysed by the difference between the psoriasis and healthy control groups at the Phylum, Class and Order levels. A-C, Difference analysis using Metastats showed significant differences of microbiota between the psoriasis and healthy control groups at the Phylum, Class and Order levels ( Figures 3A and S2A) . At the genus level, we found that Akkermansia was less abundant, while the abundance of Enterococcus and Bacteroides was increased in patients with psoriasis ( Figures 3B   and S2B ). In accordance with this, the abundance of Akkermansia muciniphila was reduced, and Clostridium citroniae was much higher in psoriasis groups compared with healthy controls at the species level ( Figure 4A ).
| The ROC curve analysis of the cut-off value with Akkermansia muciniphila and Clostridium citroniae in patients with psoriasis
Finally, the receiver operating characteristic (ROC) curve was conducted to determine the appropriate cut-off value of A. muciniphila and C. citroniae in psoriasis. The ROC curve showed moderate value in diagnosing psoriasis based on A. muciniphila and C. citroniae, as shown in Figure 4B . The sensitivity and specificity were 71.4% and 92.9%
with A. muciniphila and 71.4% and 78.6% with C. citroniae, respectively ( Figure 4B ). Following this condition, the appropriate cut-off was set at 5.47% for distinguishing the microbiota features in healthy control and patients with psoriasis.
| DISCUSSION
In this study, although there is a slight alteration in the total diversity of microbiota between psoriasis and healthy control, we found the abundance of A. muciniphila is remarkably reduced in patients with psoriasis ( Figure 2D ). This bacterium is Gram-negative and resides in the intestinal tracts of humans and animals, and it belongs to Verrucomicrobia (phylum), Verrucomicrobiae (class), Verrucomicrobiales (order), Verrucomicrobiaceae (family), Akkermansia (genus) and muciniphila (species). Under normal conditions, the population of A. muciniphila composes approximately 3%-5% of the intestinal species in an adult colon and accounts for more than 1% of the total microbiota in the stool, suggesting that this bacteria is one of the most abundant in the microbial community. [44, 45] Recent studies showed that A. muciniphila could associate with intestinal cells to maintain cellular barrier function, while a dietary intervention study demonstrated that A. muciniphila may act as an indicator of health status. [46] Evidence has shown the abundance of A. muciniphila is significantly reduced in patients with chronic inflammatory diseases, including obesity, as well as various intestinal diseases such as Crohn's disease. [47] [48] [49] The intestinal epithelial layer forms a "contact surface" for the communication between the gut microbiota and host, and a variety of antimicrobial peptides such as defensins and C-type lectin are produced by intestinal cells that play key roles in host immunity and homoeostasis. The intestinal barrier is strengthened through the mucus layer and immune factors produced by the host, [50] and a compromised F I G U R E 3 The relative abundance of microbiota analysed by the difference between the psoriasis and healthy control groups at the Family and Genus levels. A, B, Difference analysis using Metastats showed significant differences of microbiota between the psoriasis and healthy control groups at the Family and Genus levels
The relative abundance of microbiota analysed by the difference between the psoriasis and healthy control groups at the Species level. A, Difference analysis using Metastats showed significant differences in the microbiota between the psoriasis and healthy control groups at the Species level. B, The receiver operating characteristic (ROC) curve (c) showed the ability to distinguish between the psoriasis and healthy control groups barrier is associated with diseases such as Crohn's disease and obesity.
Increasing the amount of A. muciniphila attenuates diet-induced obesity and restores gut barrier dysfunction in mouse models. [48, 51] Psoriasis, IBD and obesity are immune-mediated chronic inflammatory diseases, and evidence has demonstrated that psoriasis, IBD and obesity have shown some common pathogenic features, including immune responses (Th17, Th1 and Treg) and inflammatory cytokine profiles (eg TNF-α, IFN-γ, IL-12, 17 and 23). In this study, we found the abundance of A. muciniphila was significantly reduced in patients with psoriasis, which is also a feature in patients with IBD and obesity, thereby providing a novel angle to understanding the pathogenesis of psoriasis.
Taken together, our study showed that the proportion of intestinal microbiota is altered in psoriasis, including A. muciniphila, which provides novel insight into understanding the pathogenesis of psoriasis through the human intestinal microbiota. Additional studies remain to be performed to deepen our understanding of the role of the gut microbiota, including A. muciniphila, in psoriasis pathogenesis and exploring the possibility of preventing or intervening in psoriasis through the gut microbiota.
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FIGURE S1
The heat map of microbiota analysed by the difference between the psoriasis and healthy control groups at the Phylum, Class and Order levels (A&B&C)
FIGURE S2
The heat map of microbiota analysed by the difference between the psoriasis and healthy control groups at the Family and Genus levels (A&B) 
